Discover 661 paid clinical trials in Sheboygan, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 661
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
for
Prostate Cancer,
Location: Milwaukee WI, Madison WI, Chicago IL, Rochester MN,
Sponsor: Janux Therapeutics
Sex: Male
Age: 18 - 70+
Code: NCT05519449
Phase1, Recruiting
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
for
Breast Cancer
Location: Milwaukee WI, Madison WI, Grand Rapids MI,
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06492616
Phase3, Recruiting
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
for
Chronic Phase Chronic Myelogenous Leukemia
Location: Milwaukee WI, Detroit MI, Buffalo NY, New York NY,
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04838041
Phase2, Recruiting
Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique
for
Brain Metastases
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT05045950
Phase2, Recruiting
MRI-Guided Adaptive Radiation Therapy for Organ Preservation in Rectal Cancer
for
Rectal Adenocarcinoma
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04808323
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pancreatic Cancer Adaptive Neoadjuvant Chemotherapy Trial
for
Pancreatic Cancer
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT03322995
Phase2, Recruiting
Social Relationships and Accelerated Aging in Hematopoietic Cell Transplant Survivors
for
Hematopoietic and Lymphoid Cell Neoplasm
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18+
Code: NCT04892823
Recruiting
Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutated Cholangiocarcinoma
for
Cholangiocarcinoma
Location: Milwaukee WI, Chicago IL, Charlottesville VA,
Sponsor: Genfit
Sex: All
Age: 18+
Code: NCT05874414
Phase1, Phase2, Recruiting
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Location: Milwaukee WI, Chicago IL, Westwood KS, Durham NC,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT06116110
Recruiting
MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)
for
Cancer
Location: Milwaukee WI
Sponsor: Sameem M. Abedin, MD
Sex: All
Age: 18+
Code: NCT05802069
Recruiting
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
for
Heart Failure, Heart Failure With Reduced Ejection Fraction
Location: Milwaukee WI, Naperville IL, Munster IN, Detroit MI,
Sponsor: Cytokinetics
Sex: All
Age: 18 - 70+
Code: NCT06736574
Phase3, Recruiting
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
for
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma,
Location: Milwaukee WI
Sponsor: Medical College of Wisconsin
Sex: All
Age: 18 - 70+
Code: NCT05990465
Phase1, Recruiting
KRT-232 Versus Best Available Therapy for the Treatment of Subjects With Myelofibrosis Who Are Relapsed or Refractory to JAK Inhibitor Treatment
for
Primary Myelofibrosis (PMF),
Location: Milwaukee WI, Chicago IL, Saint Louis MO, Canton OH,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03662126
Phase2, Phase3, Recruiting
A Registry to Capture Patient Outcomes With KRAS G12R Altered Advanced Pancreatic Ductal Adenocarcinoma Treated With MEK Inhibitor-based Combination Therapy
for
Pancreatic Ductal Adenocarcinoma
Location: Milwaukee WI
Sponsor: Mandana Kamgar, MD
Sex: All
Age: 18+
Code: NCT05630989
Recruiting
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Molecular Analyses to Predict Pathways of Endocrine Resistance Following Short Term Neoadjuvant Endocrine Treatment in Patients With Hormone Receptor-Positive HER2-negative Breast Cancer